Displaying 1281 - 1300 of 1575
FTC/DOJ Hearings on Health Care and Competition Law and Policy
FTC/DOJ Hearings on Health Care and Competition Law and Policy
Fourth Session of FTC/DOJ Health Care and Competition Law and Policy Hearings to Be Held April 23-25
Pfizer, Pharmacia Will Divest Assets to Settle FTC Charges
FTC/DOJ Hearings on Health Care And Competition Law and Policy
Third Session of FTC/DOJ Health Care and Competition Law and Policy Hearings Begins Wednesday, April 9
Quest Diagnostics Inc.orporated and Unilab Corporation
Quest Diagnostics settled FTC charges that its proposed acquisition of Unilab Corporation would substantially increase concentration in the clinical laboratory testing services market by agreeing to divest clinical laboratory testing assets in Northern California to Laboratory Corporation of America.
Federal Judge Issues Record $7 Million Fine Against Boston Scientific Corporation
Boston Scientific Corporation, U.S.
FTC/DOJ Hearings on Health Care And Competition Law and Policy
FTC/DOJ Hearings on Health Care and Competition Law and Policy
Second Session of the FTC/ DOJ Health Care and Competition Law and Policy Hearings Begins on Wednesday, March 26, 2003
FTC/DOJ Hearings on Health Care And Competition Law and Policy
Announced Actions for March 18, 2003
FTC Charges Bristol-Myers Squibb with Pattern of Abusing Government Processes to Stifle Generic Drug Competition
Health Care and Competition Law and Policy Hearings
FTC/DOJ Release Agenda for Upcoming Sessions of Joint Health Care Hearings
FTC/DOJ Release Agenda for First Session of Health Care Hearings
FTC Staff Issues Advisory Opinion Regarding Proposed Formation of Physicians' Healthcare Advocacy Group in Dayton, Ohio
Displaying 1281 - 1300 of 1575